Evan H. Leibowitz, MD

Chief, Rheumatology, Valley Medical Group

Evan Leibowitz, MD
Specialties
Rheumatology
Gender
Male
Languages
English
Valley Medical Group
Member, ColigoCare
ColigoCare is a network of physicians working collectively to provide the highest quality care to patients and the community.

Location(s)

Valley Institute For Rheumatology & Autoimmune Diseases

1200 East Ridgewood Avenue
Suite 306 East
Ridgewood, NJ 07450
Phone: 201-389-0096
Fax: 201-857-8771

Education

Education

NA, New York University College Of Dentistry, 1991 - 1992

MD, University Of Medicine And Dentistry Of New Jersey, 1992 - 1996

BA, Rutgers University, 1987 - 1991

Fellowships

Hospital For Special Surgery, Rheumatology, 1999 - 2002

Internship & Residency

New York Presbyterian Hospital, Internal Medicine, 1996 - 1999

Board Certifications

Subspecialty Board Of Rheumatology - Certified, 2002

Get to Know Me

What are some of the specific conditions you treat?

Rheumatoid arthritis, systemic lupus, erythematosus, vasculitis, scleroderma, gout, polymyositis, dermatomyositis, sjogrens syndrome, pseudogout.

Techniques/Procedures: 

Ultrasound-guided injections.

Describe some of your professional highlights.

New Jersey Rheumatology Association - President, 2015-2016

What would you like patients to know about your approach to care?

Rheumatology requires a close partnership between me and my patients. I listen closely to their symptoms, which helps to quickly make an accurate diagnosis. I strongly consider my patient's point of view with regards to coming up with treatment plans that they are comfortable with.

Awards & Accolades

Top Rheumatologist
Castle Connolly - New York Metro Area
2007-2015

​Gold DOC Award
Arnold P. Gold Foundation
2011

Publications & Research

Clinical Trials

“A multicenter, open-label (Part A) followed by a randomized, double-blind, parallel-group, placebo-controlled study (Part B) to evaluate maintenance of remission in subjects with active axial spondyloarthritis (axSpA) receiving either Certolizumab pegol 200mg Q2W or 200mg Q4W as compared to placebo.”

This study is focused on treating patients with ankylosing spondylitis.  We are looking for patients that are 45 or younger who have ankylosing spondylitis. All patients get treated with Cimzia for one year. Cimzia is already approved to treat the condition.  If patients are doing well on the medication, (in remission), the medication will be withdrawn to see if they will stay in remission off of it.  Patients will be monitored closely throughout the study.

 

Insurance

Valley Medical Group providers accept the following plans.

Patient Ratings & Comments

5

Comments are gathered from our patient satisfaction surveys.

04/25/2019
Dr Liebowitz is excellent and above his peers. always up to date on new treatments and research on Fibromyalgia. takes time, listens and conveys excellent information and education
04/23/2019
[...] Dr. Leibowitz is an all around fantastic MD.
04/20/2019
very compassionate doctor
04/18/2019
nothing but good
04/16/2019
Dr. Leibowitz is outstanding.